deferoxamine has been researched along with oleic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brychtova, K; Csollei, J; Dvorakova, L; Jampilek, J; Kalinowski, DS; Opatrilova, R; Placek, L; Raich, I; Richardson, DR | 1 |
| Brychtova, K; Dvorakova, L; Jampilek, J; Kacerova, S; Kalinowski, DS; Opatrilova, R; Placek, L; Raich, I; Richardson, DR | 1 |
| Annesley, TM; Hatherill, JR; Kunkel, RG; Till, GO; Ward, PA | 1 |
| Cederbaum, AI; Chen, Q; Galleano, M | 1 |
| Hart, CM; Ober, MD | 1 |
| Alta, RYP; Espósito, BP; Ortega, P; Vitorino, HA; Zanotto, FP | 1 |
7 other study(ies) available for deferoxamine and oleic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Investigating the activity of 2-substituted alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as skin penetration enhancers.
Topics: Administration, Cutaneous; Caproates; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Molecular Structure; Skin Absorption; Structure-Activity Relationship | 2010 |
Investigation of substituted 6-aminohexanoates as skin penetration enhancers.
Topics: Administration, Topical; Aminocaproic Acid; Animals; Antineoplastic Agents; Caproates; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Pyrrolidines; Skin; Skin Absorption; Stereoisomerism; Swine | 2012 |
Systemic complement activation, lung injury, and products of lipid peroxidation.
Topics: Animals; Catalase; Complement Activation; Deferoxamine; Dimethyl Sulfoxide; Elapid Venoms; Hydrogen Peroxide; Isoenzymes; L-Lactate Dehydrogenase; Lactoferrin; Lipid Peroxides; Lung; Male; Neutrophils; Oleic Acid; Oleic Acids; Rats; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Tissue Distribution | 1985 |
Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1.
Topics: alpha-Tocopherol; Antioxidants; Apoptosis; Ascorbic Acid; Aspirin; Carcinoma, Hepatocellular; Cell Survival; Chromans; Cytochrome P-450 CYP2E1; Deferoxamine; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; Oleic Acid; Phenylenediamines; Propyl Gallate; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vitamin E | 1997 |
Attenuation of oxidant-mediated endothelial cell injury with docosahexaenoic acid: the role of intracellular iron.
Topics: Animals; Bleomycin; Cell Survival; Cell-Free System; Cells, Cultured; Chelating Agents; Deferoxamine; Docosahexaenoic Acids; Endothelium, Vascular; Ferritins; Humans; Hydrogen Peroxide; Iron; L-Lactate Dehydrogenase; Linoleic Acid; Oleic Acid; Oxidants; Pulmonary Artery; Solubility; Swine; Umbilical Veins | 1998 |
Magnetite nanoparticles coated with oleic acid: accumulation in hepatopancreatic cells of the mangrove crab Ucides cordatus.
Topics: Animals; Biological Availability; Brachyura; Deferoxamine; Ecosystem; Ecotoxicology; Fluoresceins; Hepatopancreas; Iron; Iron Chelating Agents; Magnetite Nanoparticles; Male; Oleic Acid; Particle Size; Polysorbates; Transferrin; Wetlands | 2018 |